UNSPSC 51284105: Cefetamet

This classification denotes a cephalosporin antibiotic with the molecular formula C14H15N5O5S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4R5TV783X3, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-methyl-8-oxo-, (6r-(6alpha,7beta(z)))- but generally known as cefetamet, which bears US NIH Compound Identifier 5487888.

UNSPSC 51284105 Cefetamet is a Commodity code that does not align with state and local government procurement activity shown in recent solicitations. The code nominally describes cefetamet, a specific antibiotic pharmaceutical, yet the recent opportunities tagged under this code cover naloxone distribution, therapeutic pharmacy initiatives, medical and first aid supplies for fire rescue, and multi-source generic pharmaceuticals and OTC products—none of which are cefetamet or related to that specific drug. The mismatch suggests either a coding error in the state and local procurement systems or that this UNSPSC code is not actively used to classify pharmaceutical purchases in state and local government contracting.

The four recent opportunities posted between January and July 2026 reflect procurement activity in Florida, Texas, and Minnesota for broader pharmaceutical, medical supply, and pharmacy benefit programs rather than for cefetamet specifically. Issuing bodies include Seminole County, Florida; the Texas Health and Human Services Commission; the City of Tampa, Florida; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP). The opportunities span direct purchase IFBs (naloxone and deactivation systems), exploratory RFIs for pharmacy benefit restructuring, competitive sealed bids for emergency medical supplies under small local business set-asides, and multi-state cooperative RFPs for generic pharmaceuticals distributed through authorized wholesalers. The code shows little relevant recent activity for practitioners pursuing cefetamet supply contracts.